Larimar Therapeutics (LRMR)
(Real Time Quote from BATS)
$7.17 USD
+0.02 (0.28%)
Updated Aug 8, 2024 10:02 AM ET
3-Hold of 5 3
D Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.33 | 0.00% |
Earnings Summary
For their last quarter, Larimar Therapeutics (LRMR) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.32 per share. This reflects a negative earnings surprise of 6.25%. Look out for LRMR's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.33 per share, reflecting a year-over-year decrease of 57.14%.
Earnings History
Price & Consensus
Zacks News for LRMR
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
LRMR: What are Zacks experts saying now?
Zacks Private Portfolio Services